Initial Public Offering
Baird served as a co- manager on this offering.
AboutInovalon Holdings, Inc. (“Inovalon” or the “Company”) (NASDAQ: INOV) recently completed an initial public offering of 25,364,803 shares of common stock at a price of $27.00 per share, generating gross proceeds of approximately $684.8 million. The Company intends to use the net proceeds from the offering for working capital and for general corporate purposes.
Inovalon is a leading technology company that combines advanced cloud-based data analytics and data-driven intervention platforms to achieve meaningful impact in clinical and quality outcomes, utilization and financial performance across the healthcare landscape. Driven by data, Inovalon identifies gaps in care, quality, data integrity and financial performance, while also bringing to bear the capabilities to resolve them. Supporting hundreds of healthcare organizations in 98% of United States’ counties and Puerto Rico, the Company’s analytical and data-driven intervention platforms are informed by data pertaining to more than 744,000 physicians, 244,000 clinical facilities and more than 118 million Americans, providing a powerful solution suite that improves quality and economics for health plans, ACOs, hospitals, physicians, patients and researchers. Inovalon is headquartered Bowie, Maryland.
For additional information about this transaction, please contact:
- February 2015
- Inovalon Holdings, Inc.
- Target Location
- North America